Dietary supplement. Promotes good health. Regular
pectin, a soluble dietary fiber naturally present in
citrus fruit, cannot be absorbed by the human
digestive tract. However, PectaSol-C employs an
enzymatic modification process (non-GMO) which
creates smaller polysaccharide fragments that can be
easily absorbed and utilized in the body. EcoNugenics
PectaSol-C is made up of short chains of the proper
molecular weight verified in recent scientific studies.
The constituents of Modified Citrus Pectin that are
believed to be responsible for its beneficial properties
are the galactosyl fractions. Their toxin-binding
properties in the bloodstream may help promote good
health. (These statements have not been evaluated by
the Food and Drug Administration. This product is not
intended to diagnose, treat, cure or prevent any
disease.) The natural color of the powder may have
slight variations. Suitable for vegetarians and contains
no dairy, egg, gluten, corn, soy or wheat. Contains no
preservatives or artificial color, flavor or fragrance.
New Modified Citrus Pectin
Slows Cancer Progression and
Stops Cancer Cells in Their Tracks
Study Shows New Modified Citrus Pectin Works as Well as Chemo, Without Toxicity, and Improves
Quality of Life in Advanced Disease
SANTA ROSA, Calif.--(Business Wire)-- Better Health Publishing announced today that many people with cancer could be helped by
a new form of Modified Citrus Pectin (MCP)that may work as well as chemotherapy in advanced disease stages; yet without the
dangerous toxicity. These published findings of new capabilities for MCP have the potential to revolutionize integrative cancer
Previous research with MCP has shown it to be effective in slowing the progression, metastasis and angiogenesis of several types of
cancer. Now with further improvement in the modification process, more of the effective substance can be utilized by the body. The
first human study described below was done with patients with late stage, breast, prostate, colorectal, kidney, pleural or lung,
cervix/uterine cancer, liver, pharynx, pancreatic, stomach, melanoma and bile duct cancers.
This landmark clinical trial was published in the peer-reviewed journal Clinical Medicine: Oncology, where it showed a significant
improvement of quality of life and stabilization of disease for patients with advanced solid tumors. The results of the landmark
advanced tumor study clearly demonstrate MCP's enhanced capabilities.
"This is a very important breakthrough destined to help a lot of people," said Dr. Isaac Eliaz, a prominent doctor of Integrative
Medicine and MCP researcher. "MCP may have the benefits similar to chemotherapy in advanced cancers, but without the side
effects. This study sheds additional light on the potential benefits of MCP in cancer prevention and treatment."
A background report on the development of MCP in integrative cancer healthcare is available through Better Health Publishing at the
following url: www.betterhealthpublishing.org/mcpreport
MCP, a natural substance modified from the peel of citrus fruit has been used during the past decade in integrative cancer therapy
tom help keep aberrant cells from clustering and blocking the formation of blood vessel attachment. The absorption into the blood
stream is based on the size and weight of its molecules.
MCP molecules bind to receptors on cancerous cells, preventing these cells from attaching to healthy tissue and blocking the
formation of blood vessels to feed the cancerous cells. Once this has occurred, the cancer cells starve and die or are eliminated by
the immune system.
In the past, the enzymatic modification process produced too much total breakdown of the pectin molecules when it tried to achieve
the effective low molecular weight absorbable chains. The new MCP also goes through an enzymatic process that reduces the
pectin's molecular size and modifies it to better control the amount of total breakdown of the citrus pectin. These new developments
led to an improved MCP, lower in weight, which allows it to be more systemic, circulating through the blood stream and allowing the
body to absorb more of the effective molecules.
Treatment and Scientific Data of Study:
The treatment in the advanced tumor and previous studies consisted of the oral intake of five grams of MCP three times a day. One
cycle of therapy was defined as four weeks of treatment. Objectives were clinical benefit (pain, functional performance, weight
change), safety, tumor response (RESIST criteria) and quality of life.
The results proved very exciting. Forty-nine patients (between 36 and 82 years old) with various advanced solid tumors were enrolled.
Twenty-nine patients were evaluated for clinical benefit after two cycles of treatment. All patients tolerated the therapy well without
any adverse effects. The results also demonstrated that after two cycles of oral intake of MCP, 6/29, (20.7%) had an overall clinical
benefit with a stabilization or improvement of life quality. On intent to treat basis 11/49 patients (22.5%) showed a stable disease
after two cycles and 12.3% had a SD for more than 24 weeks. One patient with advanced and hormonal resistant prostate cancer
had a 50% decrease in PSA with significant improvement in his quality of life. Most of the patients had improvements in their life
quality as reflected in the Karnofsky scores.
The MCP used in the advanced tumor study is now commercially available in the US. It's called PectaSol-C and distributed by
EcoNugenics, Santa Rosa, CA.
About Better Health Publishing:
Better Health Publishing, founded by Isaac Eliaz, M.D. is a publishing house that focuses on the publication of key works promoting
health and wellness. The staff at Better Health Publishing believes that a natural and efficacious lifestyle is the cornerstone of a return
to healthy and sustainable society. The works published by BHP strive to promote this concept and disseminate to the public a
For more information on Dr. Eliaz, log onto
www.dreliaz.org. For a free report on MCP log onto www.betterhealthpublishing.org/mcpreport
The St John Group
Connie St. John, 415-454-2243
Copyright Business Wire 2008
Safety Information: Do not exceed suggested use.
Take this product with large amounts of fluids.
If you do not drink enough liquid, the product may cause constipation.
Discontinue use if intestinal discomfort or constipation occurs.
Homozon is a wonderful compliment to PectaSol-C.
To prevent the constipation that can accompany PectaSol-C use,
consider Homozon. Homozon is a powerful bowel cleanser and
natural stool softener.
For more info on Homozon, please see our sister site:
The Original Homozon, or go to our Homozon product page on this
site, located here:
If you are pregnant or breastfeeding, on medication, or have diabetes or an
intestinal disorder, consult your health care professional before using this product.
Do not use if either tamper-evident seal is broken or missing.
Keep out of the reach of children.
PectaSol-C Modified Citrus Pectin 5g; Total Carbohydrate 4g; Dietary Fiber 3g;
Sodium 180mg; Potassium 420mg
Store in a cool, dry place. Suggested Use: For active support take 1 scoop (5
grams), 3 times a day with fresh water or juice. For long term maintenance take 1
scoop (5 grams) daily, or as directed by your health care provider. This product
should be taken on an empty stomach (30 minutes before eating, or 2 hours after),
and away from other medication(s).
Modified Citrus Pectin Powder -- 150 g
Retail price: $44.97
ET Price $40.00
Count: 150 g
Serving: 1 Scoop (5 g)